For Pharma

Power brand outcomes with personalized engagement

One platform to accelerate drug launches, supercharge your hub and PSP programs, and deliver validated outcomes across your entire portfolio — in weeks, not quarters.

How We Help

Built for the way pharma actually works

From pre-launch planning to post-market persistence, Medisafe plugs into your existing workflows and amplifies every patient touchpoint.

01
02
03
03

Hub & PSP Acceleration

Turn enrollment into engagement

Your hub captures the patient. Medisafe keeps them. We extend your PSP programs with behavioral engagement that drives fill rates, reduces abandonment, and gives your hub teams real-time visibility into patient progress.

  • Bridge the gap between enrollment and first fill
  • Automated refill and appointment reminders to reinforce adherence
  • Real-time patient status signals to flag drop-off risk
  • Progress tracking and feedback loops to drive persistence
  • Copay and affordability program integration

Drug Launch Support

Faster time-to-impact for new therapies

Launch branded digital drug companions alongside your therapy — not months later. Medisafe's configurable platform lets you go live with personalized patient engagement in weeks, building early adherence patterns that drive long-term persistence.

  • Deploy branded experiences before or at launch
  • Therapy-specific onboarding and titration support
  • Early adopter cohort tracking and real-time analytics
  • Rapid iteration based on live patient behavioral data

Portfolio-Wide Orchestration

One platform across every brand and market

Stop managing a patchwork of point solutions. Maestro gives commercial and medical teams a single orchestration layer to design, deploy, and optimize patient journeys across your entire therapeutic portfolio.

  • Multi-brand, multi-market deployment from one instance
  • Centralized analytics and cross-brand benchmarking
  • Configurable journeys per therapy, population, and market
  • Enterprise governance, SSO, and compliance controls

Clinical Trial Support

Better retention, richer patient data

Improve trial participant adherence and retention with digital engagement that reinforces protocols, captures patient-reported outcomes, and provides behavioral signals that complement clinical endpoints.

  • Protocol adherence reminders and education
  • ePRO and symptom tracking integration
  • Participant retention through behavioral engagement
  • De-identified behavioral insights for study teams
Validated Results

Outcomes your leadership team can count on

Every metric validated through independent research with IQVIA, Vanderbilt University, NIH, and Komodo Health.

Program ROI up to
Up to
50x
Adherence lift in specialty therapies
43
%
Increase in time on therapy
17
%
Reduction in claims events
34
%
60-day patient retention
93
%
Faster time-to-market vs. custom builds
75
%
Enterprise-Grade Security
Built for the regulatory rigor pharma demands

HIPAA

/

SOC 2 Type II

/

GDPR

/

21 CFR Part 11

/

ISO 13485

/

ISO 27001

Why Medisafe

The Medisafe Advantage

12+ years of behavioral data

The largest medication management dataset in digital health— powering predictions no other platform can make.

130+ behavioral signals per patient

JITI doesn't guess. It reads real behavioral patterns to trigger interventions before patients disengage.

Deployed in 150+ countries

Global infrastructure with localization, regulatory compliance, and multi-market orchestration built in.

Months to launch, not quarters

Configurable, ISO-compliant platform enables rapid deployment and configuration—so your branded experience goes live fast, without custom development.

What Our Partners Say
"Medisafe gave us the ability to engage patients at scale without building custom technology. The adherence lift we saw in the first 90 days exceeded every benchmark we had."

Senior Director, Patient Services

Top 10 Global Pharma Company

Ready to turn your patient programs into measurable outcomes?

See how leading pharma brands use Medisafe to accelerate launches, improve adherence, and prove ROI across their portfolio.